BioStock Studio: Clinical Trial Investigator in Chordate’s study in chronic migraine

Chordate Medical’s patient study PM007 is completed and the results indicate that Kinetic Oscillation Stimulation is an effective and safe treatment for chronic migraine. One of the Clinical Trial Investigators in the study is Emilia Tauriala, specialist in neurology and CMO at Terveystalo. Emilia joined BioStock’s studio to tell us more about the study design and results. In addition, we got to take part of her view on K.O.S and the benefits compared to current treatments. 

Watch the interview at biostock.se:

https://www.biostock.se/en/2023/04/clinical-trial-investigator-in-chordates-study-in-chronic-migraine/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se